A group of cancer survivors from the Bronx and statewide gathered outside Gov. Kathy Hochul’s NYC office on Third Avenue on ...

As tests and screenings for chronic conditions improve, Connecticut residents will have better access after lawmakers passed legislation mandating health insurance plans cover biomarker tests starting ...

Biomarker testing is critical for determining optimal therapy early in the non–small lung cancer (NSCLC) treatment process, but research shows uneven insurance coverage of these tests and inconsistent ...

The National Council of Insurance Legislators moved closer to adopting a model law Friday after a robust debate on a biomarker testing coverage regulation. Members are expected to vote in July on the ...

Advocates fear New York state could be taking a step back when it comes to biomarker testing access for those with Medicaid.

An emerging category of laboratory tests may help improve care and treatment outcomes for cancer patients, according to a recent survey by the nonprofit CancerCare, but insurers and employers do not ...

Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving. Delays in molecular testing for ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...